Prospects for development of a vaccine against the West Nile virus

Annals of the New York Academy of Sciences

Volumn 951, Issue , 2001, Pages 1-12

  Monath, Thomas P ^a  

^a Acambis   (United States)

Author keywords

ChimeriVax platform; Jennerian vaccine; Vaccine; West Nile virus

Indexed keywords

CHIMERIVAX; CHIMERIVAX JE; DNA VACCINE; EPITOPE; FORMALDEHYDE; INACTIVATED VACCINE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; NEUTRALIZING ANTIBODY; NUCLEOCAPSID PROTEIN; RECOMBINANT VACCINE; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS VECTOR; WEST NILE VACCINE; YELLOW FEVER VACCINE;

ANIMAL EXPERIMENT; CHILD; CHIMERA; CLINICAL TRIAL; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; ENVELOPE GENE; HUMAN; IMMUNIZATION; INFECTION PREVENTION; MOUSE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; UNTRANSLATED REGION; VACCINATION; VIRION; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; WESTERN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; YELLOW FEVER;

ALPHAVIRUS; ANIMALIA; EQUIDAE; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS; JENNERIA; RNA VIRUSES; WEST NILE VIRUS; WESTERN EQUINE ENCEPHALOMYELITIS VIRUS; YELLOW FEVER VIRUS (STRAIN 17D);

EID: 0035680715     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb02680.x     Document Type: Conference Paper

References (15)

1. Vaccination of geese against West Nile fever
2. Zoo birds
3. On the Japanese B-West Nile virus complex or an arbovirus problem of six continents
4. Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques
5. Immunisation with gamma globulin to Murray Valley encephalitis virus and with an inactivated Japanese encephalitis virus vaccine as prophylaxis against Australian encephalitis: Evaluation in a mouse model
6. A candidate DNA vaccine expressing West Nile virus premembrane and envelope proteins protects mouse and horse from virus challenge
7. Yellow fever/Japanese encephalitis chimeric viruses: Construction and biological properties
8. Immunogenicity, genetic stability and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax™-JE) as a live, attenuated vaccine candidate against Japanese encephalitis
9. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax™) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates
10. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: Dose-response effectiveness and extended safety testing in rhesus monkeys
11. Molecular basis for attenuation of neurovirulence of a yellow fever/Japanese encephalitis (ChimeriVax-JE) viral vaccine
12. West Nile envelope proteins: Nucleotide sequence analysis of strains differing in mouse neuroinvasiveness
13. A live, attenuated West Nile virus strain as a potential veterinary vaccine